OpenSAFELY Vaccine Coverage Report

First dose / Priority Group 1

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 91.2% 275,191 301,882 90.4% 0.7%
Sex Female 93.0% 178,227 191,709 92.4% 0.5%
Male 88.0% 96,964 110,173 86.9% 1.1%
Ethnicity White - British 92.1% 176,834 191,968 91.4% 0.7%
White - Irish 91.9% 2,303 2,506 91.3% 0.6%
White - Any other White background 82.0% 5,159 6,293 81.1% 0.9%
Mixed - White and Black Caribbean 72.1% 434 602 69.8% 2.3%
Mixed - White and Black African 63.9% 161 252 63.9% 0.0%
Mixed - White and Asian 81.8% 189 231 81.8% 0.0%
Mixed - Any other mixed background 78.3% 378 483 76.8% 1.4%
Asian or Asian British - Indian 86.1% 1,778 2,065 85.1% 1.0%
Asian or Asian British - Pakistani 72.2% 637 882 69.8% 2.4%
Asian or Asian British - Bangladeshi 79.3% 322 406 75.9% 3.4%
Asian or Asian British - Any other Asian background 80.6% 959 1,190 78.8% 1.8%
Black or Black British - Caribbean 73.4% 1,680 2,289 72.2% 1.2%
Black or Black British - African 68.7% 966 1,407 66.2% 2.5%
Black or Black British - Any other Black background 69.4% 525 756 67.6% 1.9%
Other ethnic groups - Chinese 82.4% 294 357 82.4% 0.0%
Other ethnic groups - Any other ethnic group 77.7% 903 1,162 76.5% 1.2%
Patients with any other ethnicity code 91.8% 35,798 38,983 91.1% 0.8%
Ethnicity not stated 90.6% 2,499 2,758 89.8% 0.8%
Ethnicity not recorded 91.8% 43,288 47,166 91.3% 0.5%
Ethnicity (broad categories) White 91.8% 184,303 200,788 91.1% 0.7%
Mixed 73.7% 1,176 1,596 71.9% 1.8%
South Asian 81.1% 3,703 4,564 79.8% 1.4%
Black 71.3% 3,178 4,459 69.7% 1.6%
Other 78.5% 1,204 1,533 77.6% 0.9%
Unknown 91.8% 81,592 88,914 91.1% 0.6%
Index of Multiple Deprivation 1 (most deprived) 89.0% 54,166 60,872 88.1% 0.8%
2 90.0% 56,728 63,035 89.1% 0.9%
3 91.7% 58,282 63,525 91.1% 0.7%
4 92.5% 56,000 60,522 91.9% 0.6%
5 (least deprived) 93.0% 48,426 52,059 92.6% 0.5%
Unknown 85.2% 1,568 1,841 83.7% 1.5%
Clinical Risk Groups Patients in Any Clinical Risk Group 92.1% 239,848 260,421 91.4% 0.7%
Patients with Immunosuppression 92.7% 8,533 9,205 92.1% 0.6%
Patients with CKD 94.9% 71,393 75,250 94.5% 0.3%
Patients who have Chronic Respiratory Disease 93.3% 26,019 27,902 92.8% 0.5%
Patients with Diabetes 92.7% 52,885 57,050 92.1% 0.6%
Patients with Chronic Liver disease 88.7% 7,014 7,910 87.5% 1.2%
Patients with CNS Disease (including Stroke/TIA) 93.1% 142,555 153,076 92.5% 0.6%
Patients with Chronic heart disease 94.1% 102,256 108,647 93.7% 0.4%
Patients with Asplenia or Dysfunction of the Spleen 92.4% 2,135 2,310 91.5% 0.9%
Patients with Wider Learning Disability 87.7% 39,725 45,297 85.8% 1.9%
Patients with Severe Mental Health 84.9% 25,578 30,142 83.6% 1.2%
Other Groups Patients who are shielding (High Risk from COVID-19) 94.2% 199,556 211,806 93.9% 0.4%
Patients with Morbid Obesity 87.4% 7,147 8,176 85.9% 1.5%
Patients who are pregnant 42.9% 63 147 38.1% 4.8%